Loading
Cases by country, the UK and NHS pathway and other country lenses, and the expert centres with trials on record.
No country-level case numbers. This cancer is not mapped to a GLOBOCAN site.
| France | none recorded | 0 | 1,862 | 31,707 | #6 | ||
| United Kingdom | none recorded | 0 | 1,030 | 18,019 | #7 | ||
Milan · cancer center Programme: Breast surgery, Breast medical oncology | Italy | none recorded | 0 | 1,252 | 21,584 | #11 | |
Tokyo · government | Japan | none recorded | 0 | 1,599 | 21,937 | none recorded | #13 |
London · hospital Programme: Breast cancer and PARP inhibitors | United Kingdom | none recorded | 1 | 693 | 7,168 | - | |
Philadelphia, PA · consortium | United States | none recorded | 1 | 87 | 2,130 | none recorded | - |
Brussels · consortium | Belgium | none recorded | 1 | 41 | 1,109 | none recorded | - |
Newcastle, NSW · consortium | Australia | none recorded | 1 | 10 | 554 | - | |
Philadelphia · cancer center | United States | 0 | 3,148 | 54,267 | - | ||
Los Angeles · cancer center | United States | 0 | 2,039 | 33,523 | - | ||
Beijing · hospital | China | none recorded | 0 | 1,784 | 18,230 | - | |
Vienna · cancer center Programme: Austrian Breast and Colorectal Cancer Study Group | Austria | none recorded | 0 | 1,266 | 17,145 | - | |
Pittsburgh, PA · cancer center Programme: Breast cancer trials (NSABP heritage) | United States | 0 | 1,078 | 21,539 | - | ||
L'Hospitalet de Llobregat · cancer center | Spain | 0 | 988 | 14,310 | - | ||
| Italy | none recorded | 0 | 962 | 12,326 | - |
These are the things we can measure; they are not a ranking of quality. Each column is a field on the institution record or a count over what OnCo has linked; a centre that treats many patients with Male breast cancer but is thinly recorded here will look small.
Not known: OnCo holds no case-volume or outcome figures for centres, so none are shown. Where a national audit or registry publishes them, the centre's page links to it. Default order: Newsweek rank, then trials for this cancer, then research output.